Naya Biosciences Inc. has filed an amendment to its previous report to provide audited and unaudited financial statements for NAYA Therapeutics, Inc. and details about a merger agreement, including the conversion of shares and issuance of preferred stock, following its name change from INVO Bioscience, Inc.